Literature DB >> 31722459

Idiopathic frozen shoulder.

Shane Brun1.   

Abstract

BACKGROUND: Shoulder pain and stiffness affects at least one-quarter of the Australian population, with the primary care physician seeing 95% of these patients. Idiopathic frozen shoulder affects >250,000 Australians, making it a significant burden on both the individual and society. The primary care physician plays a major part in recognising the condition and formulating an evidence-based management plan in conjunction with the physiotherapist.
OBJECTIVE: This article provides the reader with an understanding of the natural history, pathophysiology, phases and clinical features of idiopathic frozen shoulder. It also outlines patients at risk of developing idiopathic frozen shoulder and addresses an evidence-based conservative approach to the management of this condition. DISCUSSION: The primary care physician plays a pivotal part in the identification and management of idiopathic frozen shoulder, with the vast majority of patients responding to conservative management. A shared care approach with a skilled physiotherapist is essential.

Entities:  

Year:  2019        PMID: 31722459     DOI: 10.31128/AJGP-07-19-4992

Source DB:  PubMed          Journal:  Aust J Gen Pract


  3 in total

1.  Risk Factors for the Onset of Frozen Shoulder in Middle-Aged and Elderly Subjects Within 1 Year of Discharge From a Hospitalization That Involved Intravenous Infusion: A Prospective Cohort Study.

Authors:  Wenping Cao; Jiangnan Chen; Jianfeng Pu; Yunwu Fan; Ye Cao
Journal:  Front Med (Lausanne)       Date:  2022-06-20

2.  Joint mobilization for frozen shoulder: A protocol for systematic review and meta-analysis.

Authors:  Junjie Yao; Chang Liu; Tingting Pang; Jiahui Li; Siyuan Lei; Jiangchun Zhang; Yufeng Wang; Qiangqiang Shang
Journal:  Medicine (Baltimore)       Date:  2022-04-08       Impact factor: 1.817

3.  Living with a frozen shoulder - a phenomenological inquiry.

Authors:  Suellen Anne Lyne; Fiona Mary Goldblatt; Ernst Michael Shanahan
Journal:  BMC Musculoskelet Disord       Date:  2022-04-04       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.